Presentation Information
[S5-1]Advancing N-of-1 Oligonucleotide Therapeutics in Japan: Establishing a Centralized Drug Discovery Model
○Tojo Nakayama1,2 (1.Neurology and Neurological Science, Tokyo Medical and Dental University, 2.Nucleotide and Peptide Drug Discovery Center, Tokyo Medical and Dental University)